Changes in selected metabolic parameters in patients over 65 receiving hydrochlorothiazide plus amiloride, atenolol or placebo in the MRC elderly trial

BACKGROUND: Treatment of hypertension reduces incidence of stroke, myocardial infarction and heart failure perhaps partly by controlling different metabolic parameters. There is limited information regarding the changes in potassium, sodium, weight, cholesterol and glucose levels in patients using a...

Descripción completa

Detalles Bibliográficos
Autores principales: Damian, Damian J., McNamee, Roseanne, Carr, Matthew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050956/
https://www.ncbi.nlm.nih.gov/pubmed/27716064
http://dx.doi.org/10.1186/s12872-016-0368-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5050956/
https://www.ncbi.nlm.nih.gov/pubmed/27716064
http://dx.doi.org/10.1186/s12872-016-0368-2

Ejemplares similares